In Denmark, the national enterprise authority has formally registered Novonesis, marking the performed merger between enzyme and cultures suppliers Novozymes and Chr Hansen. The mixed community might perchance perchance perhaps presumably possess an estimated annual income of €3.7bn.
Coming together to glean a ‘world biosolutions accomplice’, Novonesis combines both companies’ strengths and objectives to innovate and construct ‘transformative’ biosolutions that give a boost to how populations manufacture, luxuriate in and are residing, commented Novonesis CEO and president Ester Baiget.
“And now we possess gathered the brightest minds and along with my 10,000 colleagues, we can free up the limitless doubtless of biosolutions.”
Novonesis will most certainly be headed up by extinct Novozymes CEO Baiget, main a bunch dominated by other ex-Novozymes workers (excellent one-third of the contemporary govt group joins from Chr Hansen).
Veteran Chr Hansen CEO Mauricio Graber has stepped down with the introduction of Novonesis.
How will the Novonesis enterprise functions be organised?
By becoming a member of forces, the contemporary company mechanically expands its portfolio and reach. Novonesis will now lend a hand extra than 30 industries with its 10,000-glean team. Infrastructure spans round 40 R&D and utility centres and extra than 20 manufacturing web sites.
Why the title ‘Novonesis’?
The title ‘Novonesis’ comes from a mash-up between ‘novo’, that plan contemporary, and ‘genesis’ – Greek for ‘origin’ or ‘foundation’. Since Novozymes also extinct the ‘novo’ reference, as does Novo Holdings (an investor in both Chr Hansen and Novozymes), the contemporary company claims the observe is ‘globally connected with glean capabilities’ and a ‘Nordic heritage’. “These are all resources and values which will most certainly be shared by the long bustle mixed company.”
Half of the portfolio is now dedicated to biosolutions for human health (including prebiotics, probiotics and enzymes) and for food and beverage functions. ‘Human Well being’ contains Novozymes’ Human Well being and Chr Hansen’s Human Well being divisions, whereas ‘Meals & Beverages’ contains Novozymes’ Meals & Beverage and Chr Hansens’ Meals Cultures & Enzymes companies.
The latter spans substances that lengthen shelf-existence in lessons equivalent to dairy and bakery; lend a hand the microscopic one diet replace; and allege to give a boost to taste, texture, and diet in plant-primarily based meals.
The unreal half of of the portfolio is devoted to biosolutions for planetary health, including bioenergy and carbon capture technologies, as neatly as plant and animal health.
“All Novonesis choices match into three industrial enterprise areas which will most certainly be without prolong responsible for gross sales, advertising and marketing, applied analysis and buyer-driven innovation,” Lina Danstrup, head of exterior communications at Novonesis, educated FoodNavigator.
“Moreover they lead enterprise picks and topic priorities for despicable-purposeful collaboration. This displays our buyer and innovation-driven plan.”
Novonesis income synergies and sustainability ambitions
From a monetary viewpoint, there’s glean collaboration doubtless: the corporate is asking forward to annual income synergies of an estimated €200m, with an EBIT affect regarded as achievable within four years crowning glory. Mark synergies of an estimated €80-90m is in point of fact apt realised within three years crowning glory.
“Novonesis will show camouflage a 2024 monetary outlook no later than March 31. This involves extra disclose affect and advantages at some level of the F&B portfolio,” Danstrup published.
Previous 2025, Novonesis plans to ‘proceed to ship accelerated sustainable enhance’ from its reward enterprise, coupled with contemporary innovation and enhance opportunities.
As to the contemporary company’s sustainability ambitions, Novonesis is aiming for carbon neutrality by 2050. By 2030, the corporate is aiming for a 75% good deal in absolute CO2 emissions from its possess operations (scope 1 and a pair of) and a 35% good deal in absolute CO2 emissions from its supply chain (scope 3).
The merger follows, and became once conditional on, the divestment of Novonesis’ lactase enzyme enterprise to Kerry Community, which has now been popular.